Treatment of Chronic Hepatitis B (CHB) with Nitazoxanide (Ntz) Alone or Ntz Plus Adefovir (ADV) for Two Years with Loss of Hepatitis B E Antigen (HBeAg) and Hepatitis B Surface Antigen (HbsAg)
- 1 September 2008
- journal article
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 103, S150-S151
- https://doi.org/10.14309/00000434-200809001-00390
Abstract
No abstract availableThis publication has 0 references indexed in Scilit: